News – Page 143 – Endpoints News

Merck KGaA continues AI drug discovery deal spree with Biolojic Design

11 months ago

Australian life sciences VC Brandon Capital raises $180M for sixth fund

11 months ago

Illumina board agrees to spin off Grail rather than sell the cancer diagnostics firm

11 months ago

Sanofi touts Phase 3 Sarclisa data in multiple myeloma as it plays catch-up with J&J’s Darzalex

11 months ago

How FarmboxRx uses food deliveries to encourage patients to get preventive care

11 months ago

At ASCO: big readouts, revenue questions, and the ups and downs of ADCs

11 months ago

Fauci pushes back on pandemic criticisms before divided House panel

11 months ago

Agios plans thalassemia filing in US after unveiling data in transfusion-dependent patients

11 months ago

Structure's oral GLP-1 produces comparable weight loss to Lilly's oral candidate

11 months ago

After Phase 3 win, Arrowhead's RNAi chases Ionis to market entry in rare genetic disorder

11 months ago

Takeda outlines mid-stage narcolepsy data that prompted 'rapid' move into Phase 3

11 months ago

Caribou says partial HLA matching will improve durability of response to cell therapy

11 months ago

Delaware court lets Zantac lawsuits go ahead, wiping $8B+ from GSK market cap

11 months ago

Rapport Therapeutics sets out for $122M Nasdaq debut as IPO backlog seeks fresh air

11 months ago

Eli Lilly licenses preclinical antisense program designed to treat ALS, dementia

11 months ago

Exclusive: Isotope shortage forces pause of Bristol Myers Phase 3 radiopharmaceutical trial

11 months ago

A small group of melanoma patients may need far less immunotherapy with surgery, study suggests

11 months ago

Updated: With a promising new Keytruda contender, Summit prepares to spar with Merck

11 months ago

Daiichi Sankyo, AstraZeneca say Enhertu works better than chemo in certain breast cancer patients

11 months ago

AstraZeneca, J&J share new data in bids to expand reach of lung cancer drugs

11 months ago

GSK plots Blenrep’s return with more data on its ADC for multiple myeloma

11 months ago

Intellia plots Phase 3 study and a 2026 FDA submission after CRISPR therapy cuts swelling attacks by 98%

11 months ago

GenFleet highlights Phase 2 data on KRAS/EGFR combo in lung cancer

11 months ago

BMS details confirmatory trial win for KRAS inhibitor Krazati

11 months ago

First page Previous page 140 141 142143144 145 146 Next page Last page